Ignite Creation Date:
2024-05-06 @ 6:55 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05827471
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-04-25
First Post:
2023-03-26
Brief Title:
Clinical Study of QSOX1 as a Biomarker for Colon Cancer
Sponsor:
Qianfoshan Hospital
Organization:
Qianfoshan Hospital
Study Overview
Official Title:
Clinical Application of Sulfhydryl Oxidase QSOX1 as a New Biomarker of Colon Cancer
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to determine whether the secreted protein QSOX1 can be used as a molecular marker for early rapid diagnosis and accurate treatment of colon cancer
Detailed Description:
The project mainly selects the tumor group represented by colon cancer and the corresponding healthy people as the control group with about 100 cases in each of the two groups Mainly collect blood and tumor tissue samples of patients detect the expression of QSOX1 in the above samples and explore the role in the diagnosis and prognosis evaluation of colon cancer
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None